ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,929Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 676

$1.33M Total Retail Price of All Prescriptions

Rank: 22 out of 676

909 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 909 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

26% of this provider’s 909 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 17,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,315 567 S3 1 1
FUROSEMIDE 951 767 2 4
OMEPRAZOLE 805 585 3 2
POTASSIUM CHLORIDE 487 423 4 9
GABAPENTIN 444 329 5 10
DONEPEZIL HCL 420 400 6 24
CIPROFLOXACIN HCL 393 289 7 45
AMLODIPINE BESYLATE 375 303 8 3
LISINOPRIL 358 203 9 5
AZITHROMYCIN 335 244 10 39
METFORMIN HCL 329 255 11 8
DIOVAN HCT 328 228 12 41
NEXIUM 289 185 13 23
ZOLPIDEM TARTRATE 278 135 14 21
CITALOPRAM HBR 268 194 15 17
NAMENDA 266 261 16 35
SIMVASTATIN 262 210 17 6
LEVOTHYROXINE SODIUM 242 195 18 7
ATORVASTATIN CALCIUM 235 161 19 20
CLOPIDOGREL 229 183 20 28
HYDROCHLOROTHIAZIDE 229 182 20 12
SYNTHROID 228 166 22 48
MELOXICAM 218 158 23 13
BACLOFEN 217 78 24 144
TAMSULOSIN HCL 194 180 25 38
ALLOPURINOL 188 168 26 31
LYRICA 188 108 26 57
MIRTAZAPINE 186 162 28 59
MECLIZINE HCL 186 158 28 83
WARFARIN SODIUM 185 149 30 18
METOPROLOL TARTRATE 185 150 30 22
PLAVIX 183 148 32 40
NABUMETONE 180 158 33 179
METOPROLOL SUCCINATE 179 148 34 14
AMLODIPINE BESYLATE-BENAZEPRIL 177 129 35 44
TRAMADOL HCL 162 106 36 19
POLYETHYLENE GLYCOL 3350 161 125 37 56
GLYBURIDE-METFORMIN HCL 160 118 R 38 76
PREMARIN 150 99 R 39 128
ATENOLOL 146 112 40 25
AMITRIPTYLINE HCL 142 52 R 41 46
DICLOFENAC POTASSIUM 136 105 42 199
ESCITALOPRAM OXALATE 135 91 43 73
CELEBREX 134 123 44 108
CARVEDILOL 131 87 45 15
CYMBALTA 126 68 46 47
PHENYTOIN SODIUM EXTENDED 123 61 47 88
AMOX TR-POTASSIUM CLAVULANATE 121 81 48 136
EXFORGE 120 81 49 132
SERTRALINE HCL 119 85 50 26
TIZANIDINE HCL 119 25 50 68
RISPERIDONE 117 82 52 69
SULFAMETHOXAZOLE-TRIMETHOPRIM 116 87 53 74
PANTOPRAZOLE SODIUM 115 107 54 42
PRAMIPEXOLE DIHYDROCHLORIDE 114 83 55 204
COUMADIN 113 93 56 193
PRAVASTATIN SODIUM 112 49 57 11
CRESTOR 110 97 58 29
PROMETHAZINE HCL 109 42 R 59 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 90 60 16
DIOVAN 105 93 60 37
TRIAMTERENE-HCTZ 98 94 62 43
VENLAFAXINE HCL ER 96 55 63 98
TRAMADOL HCL-ACETAMINOPHEN 95 67 64 148
FAMOTIDINE 92 59 65 64
FLUCONAZOLE 91 53 66 115
QUETIAPINE FUMARATE 89 66 67 72
DIGOXIN 88 84 68 52
BENICAR HCT 85 45 69 180
PREDNISONE 84 48 70 53
FENTANYL 84 49 S2 70 93
DETROL LA 83 77 72 166
RANITIDINE HCL 83 75 72 27
KLOR-CON 10 83 60 72 95
CLOTRIMAZOLE-BETAMETHASONE 82 69 75 170
CYCLOBENZAPRINE HCL 81 19 R 76 50
ROPINIROLE HCL 81 57 76 85
LANSOPRAZOLE 78 59 78 171
DILTIAZEM HCL 76 46 79 227
BYSTOLIC 75 55 80 96
LANTUS 74 66 81 55
LEVOFLOXACIN 74 53 81 91
TOPIRAMATE 72 40 83 141
ISOSORBIDE MONONITRATE ER 72 65 83 54
GLIMEPIRIDE 68 62 85 30
CLONIDINE HCL 68 40 85 32
HYDROXYZINE PAMOATE 68 50 R 85 184
KLOR-CON M20 67 46 88 67
TRAZODONE HCL 66 46 89 36
NOVOLIN 70-30 66 42 89 181
ACTOS 66 63 89 106
HYDROXYZINE HCL 66 41 R 89 225
AVODART 65 65 93 199
CLARITHROMYCIN 64 45 94 256
LEVEMIR 64 49 94 157
LIPITOR 63 49 96 94
SPIRONOLACTONE 62 62 97 62
TERAZOSIN HCL 61 45 98 145
PAROXETINE HCL 61 31 98 65
NAPROXEN SODIUM 60 31 100 194
DEXILANT 60 43 100 155
GLIPIZIDE 59 38 102 81
OLANZAPINE 59 50 102 125
LEXAPRO 58 41 104 210
GLYBURIDE 58 57 R 104 92
ATENOLOL-CHLORTHALIDONE 57 55 106 142
NAPROXEN 57 37 106 71
NOVOLIN R 56 54 108 153
ABILIFY 56 48 108 133
ADVAIR DISKUS 56 28 108 87
NYSTATIN 56 51 108 198
CILOSTAZOL 56 38 108 123
IBUPROFEN 54 25 113 102
OXYCODONE HCL-ACETAMINOPHEN 54 20 S2 113 139
MORPHINE SULFATE ER 53 30 S2 115 131
PROBENECID-COLCHICINE 53 44 115 303
HYDROCODONE BIT-IBUPROFEN 51 22 S3 117 237
KLOR-CON M10 51 35 117 195
DICYCLOMINE HCL 51 30 117 207
METOCLOPRAMIDE HCL 51 42 117 107
ESTRADIOL 51 30 R 117 109
PERPHENAZINE-AMITRIPTYLINE 50 43 R 122 317
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.